Cellyan Biotechnology Co., Ltd (HKPD)

NASDAQ: HKPD · Real-Time Price · USD

0.6443

+0.0213 (3.42%)

At close: Apr 24, 2026, 4:00 PM EDT

0.6781

+0.0338 (5.25%)

After-hours: Apr 24, 2026, 6:11 PM EDT

Cellyan Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 24, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Market Cap	15	12	-	-
Market Cap Growth	29.85%	-	-	-
Enterprise Value	14.93	10.38	0	0
Last Close Price	0.64	1.08	-	-
PE Ratio	-	-360.00	-	-
PS Ratio	0.93	0.58	-	-
PB Ratio	1.38	2.38	-	-
P/TBV Ratio	1.34	2.21	-	-
P/FCF Ratio	-	23.79	-	-
P/OCF Ratio	-	20.87	-	-
EV/Sales Ratio	0.91	0.51	-	-
EV/EBITDA Ratio	-	8.62	-	-
EV/EBIT Ratio	-	78.65	-	-
EV/FCF Ratio	-	20.80	-	-
Debt / Equity Ratio	0.28	0.30	0.30	0.46
Debt / EBITDA Ratio	5.28	1.97	0.82	0.39
Debt / FCF Ratio	-4.62	4.76	-4.67	0.43
Net Debt / Equity Ratio	-0.04	-0.13	0.35	0.28
Net Debt / EBITDA Ratio	-0.48	-0.52	0.58	0.10
Net Debt / FCF Ratio	0.42	-1.26	-3.28	0.10
Asset Turnover	1.72	2.25	2.76	3.69
Inventory Turnover	25.87	23.97	23.36	51.43
Quick Ratio	2.73	2.80	1.76	1.00
Current Ratio	2.93	2.99	2.46	1.08
Return on Equity (ROE)	-13.85%	-0.59%	54.96%	170.56%
Return on Assets (ROA)	-6.31%	-1.09%	23.21%	29.96%
Return on Invested Capital (ROIC)	-12.09%	-1.90%	40.44%	100.10%
Return on Capital Employed (ROCE)	-10.08%	2.20%	50.67%	121.84%
Earnings Yield	-4.64%	-0.28%	-	-
FCF Yield	-3.25%	4.20%	-	-
Buyback Yield / Dilution	-19.69%	-38.56%	-7.64%	-
Total Shareholder Return	-19.69%	-38.56%	-7.64%	-

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q